
SLE Mouse Models & Preclinical CRO Services
Why Preclinical SLE Models Matter
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies, immune complex deposition, and systemic inflammation affecting multiple organs, particularly the kidneys, skin, and joints. Lupus nephritis (LN), one of the most serious manifestations of SLE, remains a major challenge in disease management and therapeutic development.
SLE pathogenesis involves complex interactions among innate and adaptive immune responses, including dysregulated B-cell activation, autoantibody production, Toll-like receptor 7 (TLR7) signaling, and type I interferon pathways. These interconnected mechanisms contribute to immune dysregulation, organ-specific inflammation, and, in some cases, tissue damage.
Given the heterogeneity of SLE and its diverse clinical manifestations, selecting appropriate preclinical models is essential for investigating disease mechanisms and evaluating novel therapies. Well-characterized animal models provide model-dependent readouts, such as serum autoantibody levels, renal histopathological changes, and selected inflammatory markers, to support mechanistic research and preclinical efficacy assessment.
Disease-Relevant Induced SLE Models
| Model | Mouse Platform | Application | Action |
|---|---|---|---|
| Pristane-Induced Lupus-Like Mouse Model | BALB/c mice | Investigate long-term lupus-like autoimmune responses and characterize serum anti-dsDNA antibodies, lymphoid organ alterations, and renal histopathological findings. | |
| IMQ-Induced Lupus-Like Mouse Model | BALB/c mice | Study TLR7-associated autoimmune responses and evaluate pharmacological effects using serological biomarkers, renal injury-associated endpoints, and histopathological assessments. |
Featured Model: MRL/MpJ-Fas-KO Mouse Model
| Catalog Number | Name | Base Strain | Research Application | Action |
|---|---|---|---|---|
| C001602 | MRL/MpJ-Fasem1/Cya | MRL/MpJ | Investigate systemic autoimmunity, lymphoproliferation, and progressive lupus-associated renal pathology. |
Related Genetically Engineered Mouse Models
| Catalog Number | Name | Base Strain | Research Application | Action |
|---|---|---|---|---|
| {{ value.product_num || "--" }} | {{ value.product_name || "--" }} | {{ value.product_strain || "--" }} |
|
+
|
| Analysis Category | Specific Services | Key Applications in SLE Research |
|---|---|---|
| Autoantibody Profiling | Serum anti-dsDNA antibody assessment, including ELISA-based assays | Evaluates autoimmune activity and treatment-associated changes in serological biomarkers |
| Renal Injury Biomarkers | Urinary albumin-to-creatinine ratio (UACR) measurement | Assessment of albuminuria and treatment-associated changes in renal involvement, supports evaluation of renal involvement and treatment response |
| Renal Histopathology | H&E staining and histopathological assessment | Characterizes glomerular injury, inflammatory infiltration, tubular damage, and renal tissue changes |
| Renal Immunohistochemistry | Mouse IgG immunostaining | Supports characterization of renal immunoglobulin localization and lupus-related kidney pathology |
| Immune Cell Profiling | Flow cytometry for T-cell, B-cell, and other immune populations | Supports mechanism-oriented assessment of immune regulation and cellular responses |
| Cytokine & Molecular Profiling | ELISA, multiplex cytokine assays, qPCR, and Western blotting | Supports investigation of inflammatory mediators and target-associated signaling pathways |



